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Abstract 
Why do over 20% of children die in some poor countries, while in others only 2% die? We 
examine this question using survey data covering 278,000 children in 45 low-income countries. 
We find that parents’ education and a mother’s propensity to seek out modern healthcare are 
empirically important when explaining child survival, while the prevalence of common diseases, 
along with infrastructure such as improved water and sanitation, are not. Using a GINI 
coefficient we construct for treatment services, we find that public and private health systems are 
“equally unequal”, that is, both tend to favor children in relatively well-off households, and 
neither appears superior at improving outcomes in very poor communities. These facts contrast 
with a common view that a much-expanded public health sector is necessary to reduce child 
mortality. Instead, we believe the empirical evidence points to the essential role of parents as 
advocates for their child’s health. If we can provide better health knowledge and general 
education to parents, a private healthcare sector can arise to meet demand. We provide evidence 
that this alternative route to low mortality is indeed a reason behind the current success of many 
countries with low child mortality, including Vietnam, Indonesia, Egypt, and the Indian state of 
Kerala. Finally, we calculate a realistic package of interventions that target education, health 
knowledge and treatment seeking could reduce child mortality by 32%. 
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   I.  Introduction
What explains the large differences in child mortality rates within and across 
countries?  How can we design packages of reforms that lead to large declines in child 
mortality?  These are extremely important questions and yet, due to the complex 
combination of socioeconomic, political and medical issues they touch, we are far from 
having clear answers.
Figure 1 shows the international pattern of child mortality. In middle- and low-
income countries, the probability of a child dying before age five varies from 2% to 22%.  
Even after controlling for income, there is large variation in mortality rates that is not 
well-explained.  
When considering what may be effective at reducing mortality, the gold standard 
for evidence is the randomized controlled trial. Trial results can be used, as was done by 
the Bellagio Child Survival Study Group, to come up with a list of interventions with 
good evidence that each individual component contributes to morbidity or mortality 
decline (Jones, Steketee et al. 2003).  The authors of that study argued that we need to 
build out large public health systems in order to ensure all children receive the 24 
specified interventions.
However, from a policy perspective, such lists leave many questions unanswered.  
We can never be sure that the ideal operating conditions of intervention trials can be 
replicated closely enough when being scaled-up, and they tell us little about systemic 
design which is needed to ensure that interventions are implemented and sustained. 
An alternative means to examine how to reduce child mortality is to pose the 
question: What appears to have worked in many countries, and what has not?  If we can 
find robust relations within and across countries, and over time, this would be useful 
knowledge. If these relations are consistent with health intervention trials this would 
boost those findings, while if they are inconsistent, we would need to question how 
replicable the trial results really are.
In this paper we use household survey data covering 278,000 children in 45 
countries to address this agenda.  We ask two basic questions:  First, what is the relative 
importance of different socioeconomic, environmental, infrastructural and institutional 2
factors in explaining differences in the probability of a child surviving.  Second, what 
implications do these findings have for the design, and in particular the systemic design, 
of interventions that aim to reduce child mortality.
The Demographic Health Suvey (DHS) data we use covers 45 low-income
countries and includes over one thousand questions on individuals, households and 
villages that permit us to develop good control variables.
1  We also consider instruments 
and alternative specifications for equations to examine robustness of outcomes.  This 
permits us to deal with some of the important concerns about using survey data.
2
We motivate our empirical approach by the simple figure below:
Stages to child death
In order to die a child must be exposed to a pathogen or risk, and then develop clinical 
disease.  If the child develops clinical disease, she may be treated, and conditioned on 
treatment, she will either survive or die.  The probability of a child dying then depends on 
the joint, conditional probabilities of passing through each of these stages.  We run logit 
regressions to determine the relative empirical importance of key factors that would 
influence the probability of death at each stage.  
Our empirical results demonstrate consistently, in both single country and global 
pooled data, that the prevalence of symptoms of common diseases that kill children is not 
a good predictor for child mortality risk.  In other words, children with low mortality risk 
tend to get sick nearly as often as those with high risk (after conditioning on household 
characteristics) in poor countries.
                                                
1 The data is available at www.measuredhs.com
2 Survey data has, admittedly, many problems, with the most important being the potential for misleading 
conclusions due to a lack of sufficient controls.  However the advantage is that it permits us to examine 
outcomes in “general equilibrium”, i.e. taking into account all the socioeconomic, political, institutional 













However, we find strong evidence that actions taken after a child is exposed to 
disease are highly important when predicting mortality.  Using an index we create, we 
find that the propensity of a household to use modern healthcare is a good predictor for 
child survival outcomes.  We also find that the maternal and paternal education is highly 
significant and equally empirically important.  
We calculate that if all mothers and fathers in our sample received 6.3 and 8.3
years of schooling respectively, matching the current levels in Egypt, child mortality 
would fall by 19%.  In addition, if treatment-seeking behavior in all households was 
raised to the 53rd percentile of the population in our 45 countries, again matching the 
level in Egypt, child mortality would fall an additional 13%.
3 In contrast, were we to 
halve the prevalence of diarrhea, fever, and cough with fast breathing, we calculate that 
child mortality would fall by only 3%. If all households were allocated improved water 
and sanitation, child mortality would fall by 2%.
It is important to understand whether general education is needed, or specific 
health knowledge is more important, however our surveys do not provide sufficient child-
related health knowledge data across countries to measure this.  We do provide evidence 
from India, where there are more detailed questions on health knowledge, that health 
knowledge alone may be a major factor explaining differences in survival outcomes.    
This suggests that one route to success, amongst the countries in our dataset, is 
through better educated parents who seek out modern healthcare.  Since parents are 
naturally the greatest advocates for their child’s survival, and the treatments needed to 
prevent deaths are simple and inexpensive, it is reasonable to believe that those parents, 
armed with such education and knowledge, can prevent deaths.  It is less clear whether or 
not we need to build public healthcare infrastructure, since increased demand for services 
that should come with knowledge may itself push the private sector to expand the main 
services needed to support child health.
The WHO Commission on Macroeconomics and Health (2001) argued against
reliance on a private sector health supply in low income countries because the 
Commission thought it would be lower quality, and less equitable.  This is plausible;
                                                
3 This experiment assumes those with greater education, and those above the 53
rd Treatment percentile as 
described in section 7, remain at their current levels.4
however, public systems also tend to be biased towards the elite, so it is ultimately an 
empirical question.  Our data includes information on the relative importance of the 
public and private sector in each community and nation, so we are able to analyze 
whether the above claims are correct.  
We find no evidence that nations, or communities, with relatively large public
health systems perform better or worse than regions with larger private systems. We find
that public systems are as “biased”, in terms of the distribution of health services, as 
private systems.  They both tend to serve well-educated, wealthy people better than less-
educated, poor people. This conclusion holds when we restrict the sample to the poorest 
quartile of the population in each nation.
There are numerous examples of countries and regions with large private, or self-
financing, child healthcare services that have achieved very low mortality rates.  This 
includes “socialist” countries such as Vietnam, along with Egypt, Indonesia and the 
Indian state of Kerala.  In China, approximately 70% of health service costs are paid by 
users.  In these countries and regions, parental demand has clearly driven the supply of 
child health services, showing that it is possible to achieve large child mortality 
reductions through demand-based policies, while letting the private sector expand to meet 
that demand.
This alternative route to low mortality could be especially attractive in regions 
where the public sector is weak, volatile, or lacks sustained finances. We believe more 
well-designed research efforts, including randomized controlled trials, are needed to 
determine the potential short-term impact of such policies, and the best means to 
implement them.
The remainder of the paper is organized as follows: Section 2 presents 
background information on the causes of child deaths.  Section 3 describes our empirical 
framework and the logic behind our choice of regression equations.  Section 4 describes 
our dataset and defines key variables. Section 5 presents our regression results. In section 
6 we examine robustness and causality, and we also examine the plausibility of our key 
findings based on intervention trials and other literature.  Section 7 examines the 
implications for the design of intervention packages, and evidence regarding the need for 
building out public health services.  Section 8 presents our conclusions.5
2. Basic facts on the causes of child mortality and our empirical framework
In order to interpret our empirical work, it is important to start with some basic 
facts regarding the causes and timing of child deaths.  Figure 2 shows the probability of 
dying for a child from birth, up to age 10, as calculated from the DHS data in 45 
countries.
4  It is clear from this data that the greatest risk is around the time of birth, and 
risk stays “high” until one year of age, after which the probability of dying falls to near 
zero by age five. 
The causes of death are not recorded in the DHS survey, although there is recent 
World Health Organization (WHO) data, and work by the Bellagio Child Survival Study
Group, which provides consistent estimates (Black, Morris et al. 2003).  Figure 3 shows
these estimates for the distribution of deaths for neonates, and for non-neonates.  For non-
neonates, two thirds of deaths are due to diarrhea and acute respiratory infections, 14% 
are due to malaria and the remaining 21% to a range of smaller other causes.  Note that 
only 0.4% of child deaths are attributed to vaccine preventable disease.  Neonatal deaths 
are primarily attributed to birth asphyxiation, sepsis and congenital problems. 
5
3. Empirical Framework
Our empirical framework is based on a simple statistical model that divides the 
probability of death between the risk of exposure to disease, and the risk of death 
conditioned on exposure.  We then expand this to examine consumer choice, and the 
desired level of treatment in section 3.3.
                                                
4 The chart records the percentage of children who were in that age category 12 months prior to the survey 
and who subsequently died.
5 The bulk of neonatal and post-neonatal deaths are preventable with fairly simple treatments.  In Section 6 
we discuss the treatment regimes for the main non-neonatal causes of deaths.  Neonatal diseases are also 
preventable, with more than half related to poor delivery techniques and infections acquired around birth. 
These can be prevented through improved hygiene and trained birth attendants.  Congenital problems and 
preterm deliveries can also be reduced through better antenatal and neonatal care (see Lawn, J. E., S. 
Cousens, et al. 2005)..6
3.1 The determinants of the probability of a child death in a household
The probability that a child dies over a short period of time, P
D , can be expressed 
as the joint probability of two events: that the child be exposed to a risk or pathogen 
causing disease, and, conditional on having been exposed, that the child dies:
) , ( | ) ( ) , (                                          ) 1 ( T X E D P X E P T X D P  
X :   Vector of household and child characteristics
T:    Index of treatment pattern in response to exposure to
risks or disease 
P
D
: Probability that child dies
P
E: Probability that child is exposed to disease
P
D|E: Probability that child dies after having been exposed to
disease
Here we include a vector of conditioning variables, X, such as household wealth and 
parents’ education, that impact each probability along with a variable T, which measures 
the quantity of treatment that this household provides to children when they are sick. 
In reality, children will be exposed to multiple pathogens during their lifetime.  
Suppose we prospectively plan to observe each child, k, for Mk periods, and suppose there 
are J different pathogens that could cause deaths.  Then we can write the probability that 
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It is clear from (2) that the relation between morbidity levels and treatment to 
mortality risk could each be large or small.  If some households have access to treatment 
technologies that permit them to cure all disease episodes, then changes in morbidity will 
                                                
6 We assume here for simplicity, without loss of generality, that the mortality risk from each exposure is 
independent of other exposures.  Since our regression results are based on a linearization (or logistic 
transformation) of the true distribution, the coefficients we derive may reflect more complex relations in the 
data. 7
have only a small impact on the probability of death for those households.  When we 
compare households with access to this technology, to households without it, we’ll find 
that proxies for access to this technology will explain the greatest differences in mortality 
risk.
On the other hand, if treatment regimes are poor in every household, we may find 
that morbidity levels explain the bulk of differences in mortality.  These relations may be 
similar across regions and countries or highly variable, so it is an empirical question to 
see whether there are common trends within and across countries.
Our main regressions are based on variants of equations (2).  We run regressions 
with child survival outcome as the dependent variable based on a logistic regression 
model derived from (2).  
We also run regressions using regional averages.  We can linearize (2) around the
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The average observed mortality rate for a region can be approximated by summing the 
individual probabilities of death for each child in (3) and dividing by the total number of 
children:
7
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where D is a dummy variable set to one if child k died, ε is a regression error, bars above 
variables denote regional averages, and we suppress regional subscripts.  
In our regressions we model the risk of exposure to disease as a function of the 
average level of morbidity in the surrounding region.  We model the probability of dying,
once having been exposed to disease, as a function of household characteristics and the 
propensity to treat children, as measured by an index of child vaccinations and perinatal 
                                                
7 This equation ignores second order terms which, in the case of child mortality risk, will be small.8
care.  When implementing these regression equations we allow for clustering of error 
terms within households and regions.
3.2 The determinants of the propensity to treat
Treatment is ultimately a choice variable, and it is helpful to characterize the 
factors that determine treatment.  We derive a reduced-form regression equation for 
treatment based on the solution to a utility maximization problem where guardians face a 
trade-off between consumption and child health services, subject to a budget constraint 
and standard concavity assumptions needed to ensure a solution.
8  
This reduced form equation implies we should regress treatment on household 
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where p
T is the price of treatment services, and Xi is a vector of household characteristics 
relevant to treatment.  In this derivation, we assume that treatment is available at a 
constant price for each household.
9
4. Datasets and variable definitions
We use DHS survey data from all 45 available countries to address these 
questions.  Our population is all children born within five years of the interview date. 
Since the DHS surveys ask questions of mothers, we often use household data where we 
define households as each mother with all her children and spouse.
The DHS surveys are sponsored by USAID and are conducted in a similar manner 
in all countries.  They use common methodologies, survey questions, and manuals for 
                                                
8 The model and derivation are available on request.
9 However, the price of treatment, and the coefficients on key household characteristics, could be different 
in a public system.  For example, in a theoretical command economy treatment may be allocated equally to 
everyone, so the supply side will determine the allocation of treatment.  In a planned economy the right 
hand side variables may only be relevant if they correlate with the actual allocation mechanism of the 
planners.  We can accordingly use this equation to test whether health services are allocated differently in 
public versus private systems. 9
field workers.  The size of the survey in each country is chosen according to the 
population size and the desire to measure outcomes in specific regions. In all countries 
the population includes all women aged 15 to 49. In India there is additional information 
on village data.
During the design phase, regions are divided into primary sampling units, or 
clusters, and a random subset of these clusters is chosen to take part in the survey.  The 
clusters are generally small neighborhoods and a substantial fraction of the households in 
each cluster will be interviewed.  For example in India the average cluster size is 150 to 
200 households, and averages of 30 households are interviewed in each selected cluster. 
We implement our regressions using individual and cluster average data. In every 
regression we limit included clusters to those where at least four observations are 
available.
10
In order to implement our regressions, we need to define key variables, and create 
indicators for these variables where they are not directly available. For many of the 
variables of interest, the DHS dataset includes several related indicators.  This is valuable 
since each indicator provides additional information, however the multiplicity of 
indicators complicates the analysis when we would like to measure the specific impact of 
variables.
We decided to deal with this through a strategy outlined by Filmer and Pritchett 
(2001) when creating wealth variables from DHS data.
11 These authors used principal 
components to build single indicators for wealth based on all the variables in DHS data 
that measure aspects of wealth.  They found principal components created robust 
indicators for wealth that could be used for empirical analysis.  DHS now provides these 
indicators in their datasets for a number of countries.  We chose to follow this same 
methodology when calculating indicators for wealth, health knowledge and treatment.  
We describe several key variables below, while the appendix has a glossary 
describing all variables.
                                                
10 Due to the complications that come with missing data, and varying population at national levels, we have 
chosen not to adjust our data for sample weights when running regressions.  We are effectively assuming 
that child mortality is determined by a common empirical model in all clusters and regions, so that we can 
extrapolate from this population sample to national or global data.
11 See also Rutstein, S. O., K. Johnson, et al. (2004). 10
Child Deaths and Child Deaths 7+:
Our logistic version of regression equation (2) calls for a dependent variable that 
is set to one if a child died and zero otherwise.  For each child that was born within five 
years of the survey, we created a dummy variable, Child Deaths, to indicate the child’s 
survival outcome during the subsequent period until the time of the interview.  In order to 
separate deaths due to perinatal causes, from those after birth, we also created a variable 
“Child Deaths 7+” which is a dummy that records the survival outcome for all children 
that were alive seven days after birth.  We chose seven days because this excludes almost 
all neonatal deaths caused by risk factors during birth. Both diarrhea- and pneumonia-
related deaths start to occur after seven days.
12  
Treatment:
We want our variable “treatment” to capture the propensity for children to receive 
treatment from modern health services when they are sick.  This is calculated as a single 
indicator for each household, and we assume all children in the household receive similar 
treatment.
13 To calculate this we take all measures of preventive healthcare used by the 
family which are unlikely to have a significant impact on Child Deaths 7+, and are 
uncorrelated with whether a child is actually diseased.  The measures we used are listed 
in Table 1. We included standard WHO childhood vaccinations recommended within the 
first three months after childbirth because these are good indicators of how well children 
are integrated into receiving healthcare, but at the same time they have little or no impact 
on mortality rates as these diseases no longer cause many deaths.  In order to create one 
indicator for each household, we used data for the eldest living child that was under five 
years of age.
14,15 We also included the only two available indictors for mother’s 
                                                
12 As discussed below, due to the limited number of deaths in our dataset, the power of our single country 
regressions is generally low.  By including deaths that occur between 7 and 28 days, i.e. within the neonatal 
period, we increase the overall power.  The point estimates for coefficients are similar regardless of the 
timeframe chosen.
13 Girls and boys may be treated differently; however for the purposes of this paper we have not examined 
this question.
14 The Bellagio Child Survival Study Group estimated that only 0.4% of child deaths are due to diseases 
which could be prevented with the standard WHO vaccinations.  We have excluded measles vaccination 
from our indicator since it is only due nine months after a child is born, and so it would lead us to exclude 
families where the only available vaccine records were for children aged between 4 and 9 months. We
chose children under five years of age to limit recall bias, and we picked the eldest child in order to limit 11
treatment-seeking during pregnancy: antenatal care and whether mothers delivered babies 
at their home or institutions.  These indicators will correlate directly with neonatal 
mortality rates but they should have no direct impact on deaths after seven days of age, 
i.e. Child Deaths7+ .  
We calculate our Treatment indicator from the first principal component of the 
above healthcare indicators.  Table 1 shows simple characteristics of our treatment 
indicator and its relation to the underlying components from global data.  A higher 
treatment indicator is correlated with more antenatal care and more child vaccinations.  
We believe Treatment provides a good proxy for the relative propensity of children to be 
treated by modern healthcare.
Morbidity Indicators:
The three main causes of child deaths are pneumonia, diarrhea and malaria. The 
WHO has defined conditions under which children should be treated for suspected cases 
of each of these diseases respectively, and a rubric is listed in Table 2.  The DHS surveys 
ask mothers whether their children had watery or bloody diarrhea in the previous two
weeks, whether their children had coughs with rapid breathing (symptoms of acute 
respiratory infection and suspected pneumonia), and whether they had a fever (symptom 
of malaria). These questions roughly match the WHO rubric for children that require 
further treatment and the definitions used in intervention studies measuring the efficacy 
of interventions that target morbidity.
16
For each child we created a dummy variable reflecting whether any child under 
five years of age in the household, at the time of the survey, had symptoms of disease.  
                                                                                                                                                 
any endogeneity that could arise if younger children, who are born after a recent child death, are treated 
differently. 
15 Aaby, P. and H. Jensen (2005) argue that the non-specific impact of measles vaccines may lead to greater 
survival than could be explained by reduced measles fatalities alone.  This finding remains controversial, as 
discussed by  Fine, P. E. (2004), and has not been confirmed in well-designed prospective trials, but would 
suggest that measles vaccination may directly explain survival despite the low number of measles-
attributed deaths.  As discussed above, our treatment indicator does not include measles vaccines, and there 
is no evidence of sizable survival gains from non-specific effects of the vaccines that we do include.   
16 See for example Luby, S. P., M. Agboatwalla, et al. (2004) and Luby(2005) for diarrhea and acute 
respiratory infections.  Intervention studies often define diarrhea as 3 watery stools during a 24 hour period, 
whereas the question in the DHS survey we use asks mothers if their child had any watery stools.  This will 
make our disease variable more sensitive than the standard definition but less specific. 12
We then calculated the average prevalence, for all households, of each disease in each 
sample cluster, and used this indicator as the morbidity variable for every child in the 
cluster when we run regressions at the individual level.
17 Figure 4 illustrates the large 
variation in the prevalence of diarrhea, and the prevalence of symptoms of acute 
respiratory infections (ARI), across countries in our dataset.
18
One potential problem with this data is that the surveys take place over more than 
one season in some of the larger countries, and if there is seasonality in the morbidity 
data, this could introduce noise into the morbidity variables.  In order to control for 
seasonal patterns of morbidity, whenever we run regressions with disease incidence we 




The remaining variables are self-explanatory and defined in Appendix 1.
Table 3 presents sample averages and standard deviations of key variables used in 
our regressions by region and for the 20 largest countries by population.
4.2 Dealing with missing data and selection bias
Our empirical model calls for a regression of survival outcomes on child specific 
and household specific data.  An important problem here is that household data on 
treatment is only available when there is a living child.  This missing data could bias our 
coefficient estimates since the explanatory variables will be missing in households where 
                                                
17 We use the household as the indicator of disease, rather than specific children, since we assume that 
every child in the household is exposed to disease if one child has symptoms.  This is not important for any 
regression results, but given the highly infectious nature of disease, it seems the most realistic assumption.
18 We don’t have comparable data for wealthy countries; however a recent study that examined diarrhea 
prevalence in Australia, Canada, Ireland and the United States found respectively that the prevalence of 
diarrhea, defined as 3 watery stools during 24 hours, in children under 5 years of age during the previous 4 
weeks was 8.2%, 11.7%, 7.6% and 11.2% respectively (Scallan, Majowicz et al. 2005).  This is a more 
restrictive definition of diarrhea, so the figures are not comparable, although it suggests that diarrhea 
prevalence is substantially lower in these wealthy countries compared to low-income countries.
19 We checked for bias due to this in our regressions by restricting our regressions to households where 
interviews were done in similar seasons. 13
all children die, thus generating a correlation between the error term and data availability 
in our mortality regressions.
In order to deal with this problem we compare regression results when we do not 
correct for the possible bias with two alternative procedures that aim to eliminate or 
correct for any bias.  
The first is to fill in the missing data using a “hot-deck” technique common to 
survey data.  Under this technique we find a donor household, with an identical number 
of child deaths, to fill in household treatment and morbidity data in cases where all
children in the household have died by the time of the interview.
20 This “hot-deck” 
routine has the advantage of maximizing the dataset, while maintaining the statistical 
distribution, and hence increasing the power of our regressions, however, by selecting 
donors we may be introducing bias in our dataset.  
An alternative procedure to achieve unbiased estimates is to follow a variant of 
Heckman’s estimator as outlined in Wooldridge (2002).  Under this procedure we 
estimate the inverse Mills ratio using our selection equation for treatment, and then run 
an IV regression in available data to estimate our regression equation.  We run this 
regression in our global data to test consistency of our results with the hot-deck procedure 
and the uncorrected regressions.
4.3 Power calculations for our regressions
When interpreting results, it is important to keep in mind the power of our 
regressions since this will influence whether we should expect to find significant 
outcomes.
The actual power of our regressions is closely related to the mortality rate, the 
empirical importance of right hand side variables, and the sample size.  Vaeth and 
Skovlund (2004) have derived a simple rule for calculating the sample size needed to 
                                                
20 We find a donor’s treatment data according to the following hierarchy of rankings:  region, cluster, 
antenatal visits, place of delivery, mother’s education, father’s education.  Hence, donors will tend to be 
taken from mothers living in the same cluster, and having similar antenatal care, place of delivery and 
education. In order to match morbidity data, we follow the same procedure, although we use improved 
water and sanitation rather than antenatal care and place of delivery when finding matches.14
power logistic regressions adequately.  According to this rule, and using global sample 
averages from our data, we would need roughly 6,200 observations in our regression to 
capture the impact of a variable that generates a 15% change in Child Deaths 7+ in 
response to a one standard deviation change in that variable.  If we aim to capture the 
relevance of variables that have a smaller impact on Child Deaths 7+, we would need 
substantially more observations.
21
In our matched dataset we have an average 7,900 observations per country, so in 
many countries the power is adequate to demonstrate the significance of variables that 
have a large impact on mortality.  However there are eleven countries with less than 
3,000 observations. In these countries the power for a similar experiment will be roughly 
0.50, meaning that even when the right hand side variable has a large impact on 
mortality, we only have a 50% chance of finding it is significant.  This is important since 
it helps explain why outcomes are often insignificant in single country regressions.
In our global regressions we have 278,000 observations using our matched data, 
and 27,000 observations using our cluster averaged data, meaning that these are 
adequately powered to estimate the impact of variables that have a small impact on 
mortality outcomes.
5.  What factors predict child deaths?
We begin by examining the trends in single country regressions.  We then 
examine results when we pool the date from all 45 countries in our global regressions.  
Finally, we show results for the determinants of Treatment.  In section 6 we discuss the 
results further, and also examine robustness and the implications for causality.
                                                
21 The required sample size can be approximated by the sample size needed in a randomized controlled 
trial.  The trial is powered to measure a change in the dependent variable equal to two times the standard 
deviation of the right hand side variable multiplied by the regression coefficient on the right hand side 
variable found in the logit regression.  This sample size can be adjusted for multiple regressors using a 
simple formula.  In our case, the average value of Child Deaths 7+ is 0.06. The sample size required to 
measure an intervention that generates a 30% decline in Child Deathss 7+ with 80% power and 5% 
significance in a two-sided test is 4,624 per arm. When we make adjustments for multiple regressors, we 
calculate 6,165 observations are needed.  We should therefore be cautious when observing insignificant 
outcomes in these regressions, since they could still imply that the variables do have modest or small 
impact on mortality, and the insignificance reflects the fact that our regressions are not powered sufficiently 
to measure the outcomes. 15
5.1 Single country regression results: What predicts child survival outcomes?
Table 4 shows detailed logit regression results for the four most populated 
countries in our dataset as motivated by (2).  Figures 5a-g use these results to calculate 
the predicted percentage increase in the probability of a child death due to a one standard 
deviation change in right hand side variables.
There are several common trends in this data. First, Treatment, along with 
parents’ education are generally highly significant in each regression.  As illustrated in 
Figure 5, a one standard deviation rise in treatment, mother’s and father’s education 
predicts a 14%, 12% and 10% decline in child mortality respectively.  
The morbidity indicators are rarely significant, neither individually nor jointly.  
As illustrated in Figure 5b, if the cluster where a child lives moves down by one standard 
deviation in terms of the prevalence of diarrhea morbidity, the probability of a child death 
falls by only 3.7%.  
However, one potential problem with these regressions is that our indicators of 
morbidity incidence, which are measured in our data only during the two weeks prior to 
an interview, may not be a very good proxy for disease incidence during the previous five
years when mortality is measured.  Since improved sanitation and water are believed to 
reduce the incidence of diarrhea, and possibly pneumonia and malaria also, we included 
these as alternatives to morbidity indicators in our regressions.
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In Table 4, regression II, we substitute improved water and sanitation for 
morbidity variables to see whether these better predict mortality, and whether this 
changes the strong impact of treatment in our regressions.  Figures 6a-b show the 
                                                
22 A recent meta-analysis concluded that hygiene, clean water and improved sanitation can each reduce 
diarrhea incidence by 25-37% (Fewtrell, Kaufmann et al. 2005).  A randomized controlled trial that 
measured the impact of hand washing in the slums of Karachi found acute respiratory infections were 
reduced by 50%, and diarrhea by 53%, when the intervention group received education and soap for 
improved hygiene (Luby, Agboatwalla et al. 2005).  To the extent that improved water leads to better 
hygiene, it is possible that improved water will also reduce respiratory infections.  Finally, since sanitation 
is important for insect control, these measures may also reduce the incidence of malaria (Keiser, Singer et 
al. 2005).16
predictions for the impact of improved water and improved sanitation based on these 
single country regressions.
The results are very similar to those found when we used morbidity indicators 
directly.  The regressions suggest water and sanitation have no significant predictive 
power for child deaths. Improved water and sanitation are each a significant predictor of 
mortality risk in only 16.7% and 10.2% of regressions respectively.  The empirical 
magnitude of coefficients is generally small. The impact of treatment and education, not 
shown in the charts, was nearly identical to results in Figure 5.  
5.2 Global data:  What predicts child survival?
These empirical results tell us about the within-country pattern of mortality risk, 
but they provide no direct evidence regarding the explanation for cross country 
differences in mortality.  As discussed in section 4.3, one problem with the single country 
estimates is that they are not sufficiently powered to measure the impact of variables that 
have modest or small impacts on overall mortality rates.  This problem is illustrated in 
Figures 5-6 where the 95% confidence intervals around the point estimates are very wide.  
In general the coefficient estimates in Figures 5 and 6 are consistent with a Gaussian
distribution.  There are a large number of coefficients near the mean estimates, and more 
narrow tails at either end.  
Given this general consistency of results, we chose to pool the data for all 45 
countries and use regression equations to examine determinants of mortality risk within 
and across countries.  We refer to this data as the “global” data.  Since our wealth 
variables cannot be compared across countries, we permit the coefficient on this variable 
to vary for each country.  We also permit coefficients to vary on seasonal dummies for 
each country reflecting the time of year that the household was interviewed. We include 
country dummies for each nation.  We pool all other variables in our regressions.
The results from the global regressions are presented in Tables 5 and 6, while 
Figures 7 and 8 calculate the implied impact of a one standard deviation change in key 
variables on child mortality.  The five columns in Tables 5 and 6 reflect different 17
techniques used to deal with possible missing variable bias as discussed in section 3, and 
regressions where we use cluster averages instead of individual child data.  
Figures 7 and 8 show that the results do not change when we use cluster averages 
or individual level regressions, and they are also robust to alternative methods to deal 
with missing variable bias.  The results in column V of Tables 5 and 6 show that the 
inverse Mills ratio is insignificant in both regressions, which suggests any selection bias 
is small.  
In our global data we once again find that treatment is roughly twice as important 
as morbidity when predicting survival outcomes.  Our estimates of the empirical 
importance of morbidity in Figures 7 and 8 assume that all three measures of morbidity 
simultaneously decline by one standard deviation, something that would be very hard to 
engineer in practice.
The role of parents’ education is highly significant in each regression and the 
combined sum of mother’s and father’s education is roughly as important as treatment 
when predicting mortality outcomes. The variation in the point estimates on mother’s and 
father’s education probably reflects the high collinearity between these indicators.
Figure 8 graphs the implied empirical impact of each variable in the global data 
when we replace morbidity indicators with improved water and sanitation.  These results 
are based on Table 6 and illustrate that improved water and sanitation have little 
predictive power for mortality.
The fact that the cluster regressions have similar results to individual level 
regressions in Figures 7 and 8 is important.  This shows that our results are not biased due 
to household level measurement error or other contamination, and that our decision to 
include cluster averages of morbidity as regressors in the individual regressions is not the 
reason for the low predicted impact of morbidity on mortality outcomes. 
  
5.3 What determines treatment?
The previous regressions suggest treatment services and education explain large 
variations in child mortality within and across countries.  This begs the further questions: 18
why does treatment utilization vary? and are the observed differences in service 
utilization primarily due to supply or demand factors? 
In this subsection we examine regression results that attempt to explain our 
treatment variable.  Our regression results here are based on the equation (5).  Our key 
demand side variables are education and wealth.  Our public supply indicator is the 
distance to the nearest public health facility.  This variable is only available in 23
countries. Due to the paucity of data and indicators, we also turn to a different analysis of 
the role of demand and supply by looking at where households seek out treatment in 
Section 7.  
Table 7 presents results from our global regression.
23  Column I shows an OLS 
regression in all available countries when we exclude “distance to nearest public health 
center”.  Column II shows the regression results when we include this variable in the 
reduced sample of 23 available countries.  The results are similar in both regressions.
These regressions suggest education is the single most important explanatory 
variable when determining treatment.  We calculate that a one standard deviation rise in 
mother’s and father’s education would generate an 0.29 rise in treatment (measured in 
units of one standard deviation), while a one standard deviation fall in distance to public 
health center generates an 0.06 rise in treatment.  Since we have included individual 
wealth components for each country in the regression, and permitted coefficients to vary 
by country, we do not measure the impact of wealth in this regression.    
In section 6.1.4 we discuss whether education per se, or health knowledge more 
specifically, is important for reducing mortality. In Figure 9 we illustrate that there is a 
strong relation between specific health knowledge, in this case an index calculated using 
answers to questions on AIDS knowledge and family planning, and treatment in many 
countries.  However, the causality here is not clear:  perhaps households that know more 
                                                
23 We ran regressions both in the global data, and as single country regressions (not reported).  The results 
were similar in both.  The single country regressions implied that mother’s and father’s education, followed 
by wealth, were empirically the most important explanatory variables, while the dummy variable 
representing distance to public health centers was slightly less important.When measured in terms of 
standard deviations of treatment, the average single country impact of a one standard deviation rise in 
wealth, mother’s education and father’s education was an: 0.10, 0.11, and 0.08 rise in treatment.  A one 
standard deviation fall in distance to the nearest health facility generated an 0.06 rise in treatment.  These 
variables were significant at the 5% level in 78%, 78%, 70% and 65% of the single country regressions.19
go to clinics, however it could be that they learn their health knowledge because they 
visit clinics more often.    
We present this result because it could have important policy implications. If 
households get treatment because they are better informed about the need and benefits, 
then improving health knowledge could substantially raise treatment, and this in turn 
could reduce mortality rates.  Given that general education levels take much longer to 
change, and building out public infrastructure is time consuming, costly and difficult, 
then focusing on improving health knowledge could be an effective means to 
substantially change treatment-seeking and reduce child mortality.
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6.  Further discussion, robustness and causality
The regression results from Section 5 demonstrate, at the least, that the propensity 
to treat children, and parents’ education, are very good predictors of child mortality, 
while morbidity measures and access to water and sanitation are poor predictors.  We’ve 
shown the results are robust at the cluster and household level, and selection bias does not 
have a strong impact. 
In this section we focus on whether it is reasonable to believe these are causal 
relations, i.e. should we conclude that if we raised education and the propensity to treat, 
child mortality would fall by the amounts predicted by our regression equations?  
Our approach is to consider: (i) if we have adequately controlled for potential 
confounding factors and measurement error; (ii) if endogeneity of right hand side 
variables could be biasing results for improved water and sanitation; and (iii) if the large 
impact is plausible given results from intervention trials and other sources. 
                                                
24 We also ran treatment regressions in global data (not reported here) and found similar results to the 
single country regressions.20
6.1 Disaggregating our principal components and expanding the list of controls 
One problem with survey data is that we can never be sure we have sufficient and 
adequate controls to prevent biased coefficient estimates.  We’ve attempted to deal with 
this by adding multiple control variables, along with regional and urban dummies, and 
seasonal dummies to our regression equations.
6.1.1 Controls and interaction terms for malaria endemic regions
Our global regressions assume that the coefficients on morbidity variables are 
constant across countries.  If the morbidity indicators reflect different underlying diseases 
and mortality risks in different regions, then our results may be biased.  This could 
particularly be a problem for fever, which is a symptom for malaria in endemic regions, 
but would not indicate malaria in regions where there is no malaria.
In order to test whether this is biasing our results, we created a dummy variable 
for each country that was set to one or zero depending on whether the country suffered 
from endemic malaria according to data published by the WHO and Roll Back Malaria.  
We included this term, interacted with fever, in our matched-data global regressions to 
test whether there is a differential implication for fever in the malaria endemic zones.  
The impact of this change on our main regression results is illustrated in Figure 
10.  The p-value for the interaction term was 0.056, while fever on its own was 
insignificant, so the coefficient estimates do suggest that fever is only important in 
malaria endemic nations.  However, the implied impact of a one standard deviation 
change in morbidity indicators is unaffected by these changes, as shown in Figure 10, and
the implied impact of fever remained small.
6.1.2 Controls for possible ethnic elites
Our next test is to examine whether there is a third factor which is driving 
treatment, education and low mortality in our regressions.  In particular, if some regions 
or households receive preferential access to public services, say because they tend to be 21
elite ethnic groups, then our regression results may actually be picking up correlations 
with this preferential status rather than causality of specific right hand side variables.  
The DHS data includes measures of ethnic groups and castes for 26 countries 
which we can add to regressions to determine whether they change our main results. Due 
to the large number of variables (for example in Zambia there are 57 groups), we 
restricted the analysis to single country regressions. For each country where data is 
available, we have created a dummy variable equal to one for each ethnic group, and then 
run our single country regressions as described in Table 4, column I, with these additional 
variables.
The regression results suggest class may be an important indicator of mortality 
risk, but it does not bias our estimates.  We found that the ethnicity variables were jointly 
significant in 15 out of 24 regressions.  The calculated impact of a one standard deviation 
rise in treatment on mortality was –13.6% in the original regressions for these countries, 
and changed to -13.7% when we added class variables.  The impact of a one standard 
deviation rise in mother’s education changed from -10.4% to -9.9%, and the impact of 
father’s education moved from -11.3% to -10.8%.  A one standard deviation fall in 
morbidity predicted a 2.4% fall in mortality compared to 3.6% in the original regressions.  
None of the new estimates were outside the confidence intervals of the original estimates.  
6.1.3 Low birth weight and age of mother
There is a substantial literature which demonstrates that low birth weight babies, 
and children of young mothers, are at greater risk of death than older children.  The 
causality of this relation is not clear, however it could reflect poor nutrition and issues 
related to women’s rights.  
We included a dummy variable set to one if the mother was under 18 when the 
child was born, and a dummy variable set to one if the child was reported to be “small or 
very small” at birth, in our logit matched regressions.  The impact of adding these 
controls on our main regression findings are illustrated in Figure 10.  Each of these 
variables was significant in the regression, with the anticipated sign, however they did 22
not substantially affect the significance or empirical importance of treatment, education 
and morbidity indicators.  
6.1.4 Health knowledge versus education
One issue which is highly important but difficult to measure in this data is the 
relative importance of general education as compared to health knowledge.  It could be 
that health knowledge is the main factor needed to lower mortality, or it may be that 
general reasoning skills, literacy, and the empowerment that comes with education are 
essential.  
Unfortunately there are few common indicators of health knowledge across 
countries, and only one question asking “have you heard of ORT” relates to child health.  
This variable is not significant when we include it in our mortality regressions, but as 
illustrated in Figure 10, it and other health knowledge variables are highly correlated with 
our treatment indicator. We’d ideally like to have a comprehensive list of variables that 
covers issues such as beliefs regarding clean delivery practices during birth, and 
knowledge of risk signs and treatments for diarrhea, pneumonia and malaria.  
The Indian survey has one interesting variable that is closer to what we would like 
to measure.  They ask every mother whether one “should increase, maintain, or decrease 
fluids” given to a child when the child is sick with diarrhea.  The correct answer is to 
increase fluids since death from diarrhea is almost always a result of rapid dehydration.  
However, increasing fluids is counter-intuitive since children often vomit what little fluid 
they are given, and it may seem appropriate to reduce fluids until the child can take fluids 
without vomiting.
To see whether this form of health knowledge was correlated with mortality, we 
created a dummy variable equal to one if the mother believed fluids should be decreased,
an answer that is clearly wrong and would pose risks to the child,  and zero otherwise.  
Approximately 30% of mothers in India believe fluids should be decreased.  We then ran 
our mortality regressions using the matched data in India.  The results from those 
regressions showed that this variable was highly significant, with a p-value of 0.005. The 
coefficient estimate implied that a child whose mother believed fluids should be 23
decreased during diarrhea episodes had a 15.2% greater risk of death than one whose
mother did not believe this.   The inclusion of this variable had little impact on the other 
estimates. 
6.2 Feedback and endogeneity
Even if we assume that our regressions have adequate controls and there is little 
evidence of measurement error generating bias, our coefficients could be biased if there 
are feedback effects from right hand side variables to the dependent variable.  In this case 
the error term in our regression equations would be correlated with dependent variables, 
hence biasing results.
6.2.1 Could endogeneity of improved water and sanitation explain the low impact of 
these on mortality?
Our regression results suggest clean water and sanitation have a minimal impact 
on child mortality.  It is worth exploring potential reasons for this somewhat surprising 
finding. 
A recent meta-analysis of improved water, sanitation and hygiene interventions 
found that these interventions can improve diarrhea incidence by 25-37% (Fewtrell, 
Kaufmann et al. 2005).  Further, they found that the benefits of combined interventions, 
such as hygiene with clean water and sanitation together, were no greater than the 
benefits from a single measure such as clean water.  If we assume that diarrhea related 
diseases cause 31% of total child deaths, and we assume a linear relation between deaths 
and morbidity, then such measures could reduce diarrhea mortality by 8-12%.  
There is also potential for clean water to reduce acute respiratory infections if it 
contributes to better hygiene. A recent trial of hand-washing in Karachi found hand-
washing contributed to a 50% decline in acute respiratory infections when compared to 
control regions (Luby, Agboatwalla et al. 2005).   Hence the empirical relevance of water 
and sanitation could be large, or negligible, depending on the sum of these parts and the 
relation between the different morbidities and mortality.24
We ran OLS regressions using the global clustered data to examine the correlation 
between improved water or sanitation and our morbidity indicators.  In these regressions 
we controlled for wealth, mother and father’s education, urban living, seasonal dummies 
and country dummies.  The point estimates from the regressions implied that if both 
water and sanitation were improved, diarrhea would fall by 3% and fever by 4%. Each 
was significant at the 10% level. There was no significant impact on cough symptoms of 
acute respiratory infections.  
So why do intervention studies suggest improved water and sanitation reduces 
morbidity quite substantially, while our results imply only a modest impact?  Let’s start 
with a potential fault with our methodology.  It may be that improved water and 
sanitation have been supplied to some of the worst off regions, and since we do not take 
this into account in our regressions, our coefficients are biased to show less impact than is 
actually the case. 
This does not seem obvious.  Indeed, a priori we would have thought the bias 
would go in the opposite direction.  Political realities often mean that influential groups, 
regardless of relative need, actually receive improved water first.  This would bias the 
impact of water on morbidity and mortality in favor of clean water programs rather than 
against. 
6.2.1(a) Instrument for improved water from Indian village data
To examine this further, we consider a potential instrument from the Indian data 
that permits us to identify whether better quality water impacts health. The Indian DHS 
dataset includes a dummy variable for each village specifying whether the village has 
access to surface water for agricultural irrigation.  Surface water is typically polluted 
since it has not gone through natural filtration similar to groundwater, but it makes for a 
ready supply of water and so reduces the demand for an improved water supply. To the 
extent that clean water is important for health, villages with readily available surface 
water should therefore actually be worse off if they are less likely to get an improved 
water supply.25
We ran a first stage regression with improved water as the dependent variable, 
and “access to surface water for irrigation” plus our controls as explanatory variables. 
The coefficient on the irrigation term was negative, as expected, with a p-value of .005.  
We then used this as an instrument for an IV regression across Indian villages.  
The results, presented in table 8 for mortality, were nearly identical to our OLS 
regressions.  The improved water variable remained insignificant.  
6.2.1(b) Instrument for improved water using time taken to fetch water
There is a second potential instrument available in most countries reported by 
DHS that can be used to check for measurement error.  They ask each mother how much 
time is spent each day fetching water.  Those households who are far from a water source 
are likely to use less water, and may, from time to time, substitute lower quality water 
instead of making the long trip to fetch water.  Further, since they may leave water in 
containers for long periods between fetching new water, it may become more 
contaminated than someone who has a water source nearby.
We ran a first stage regression of improved water on time to fetch water, where 
the latter was measured by three dummy variables set to one if it took longer than 15, 30 
or 60 minutes to fetch water.  In our data 10.1% of families report it takes more than 60 
minutes to fetch water.
These estimated coefficients for all three dummy variables were negative as 
expected, and they were jointly highly significant with a p-value of 0.000.  We then ran 
an IV regression in our global, matched data.  The results from this regression for 
mortality in our global matched data are shown in Table 8.  The coefficient on improved 
water is still insignificant and has the wrong sign.  This regression also implies that 
improved water has little or no impact of mortality outcomes.
So what else could explain the weak impact of water and sanitation in our 
regressions?  Our guess is several factors:  
First, the intervention trials are typically done in the worst off regions, where 
water quality improvements are probably important, and yet these regions may not be 
representative of regions without improved water in our samples.  The substantial 26
increase in improved water and sanitation over the last 40 years may mean that the major 
gains from this intervention are now past.  This is the explanation chosen by Sastry and 
Burgard (2005) when discussing why improved water no longer correlates with Brazilian 
prevalence of diarrhea.
A second, and related reason, is that the availability of medicines to treat common 
diseases may make improved water less important for mortality outcomes.  The major 
improvements in improved water in Europe and the United States occurred when typhoid 
and cholera were still major causes of death, and when antibiotics and ORT were 
unavailable or unknown (Culter and Miller 2005).  The availability of vaccinations and 
antibiotics, and knowledge of ORT, has dramatically reduced death rates.
A third reason is that water quality at the source does not ensure good water 
quality in the home, or lower morbidity, unless households store water in clean 
conditions and generally maintain good hygiene (Trevett, Carter et al. 2005).  There 
could also be problems with the source if wells, pumps and pipes are not maintained 
properly.  In our morbidity regressions, mother’s education was highly significant when 
predicting household diarrhea.  This suggests hygiene behavior may be essential, rather 
than the source and plentifulness of the water, for preventing diarrhea.
Finally, intervention studies, and our regressions, focus on diarrhea as a symptom
of lethal disease.  However, diarrhea is in reality a syndrome caused by many different 
pathogens having varying mortality risk, and these pathogens can be transmitted in many 
ways.  One of the most lethal pathogens is rotavirus, which is common to high and low-
income countries, and is believed to be transmitted through a fecal-oral route.  Better 
hygiene alone, even when the water source is not improved, can eliminate the causes of
these types of diarrhea incidence.
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6.2.2 Endogeneity of wealth
A second bias would occur if child mortality directly influenced wealth.  There 
are several potential channels here.  Fatal child illness could reduce family wealth if 
                                                
25 Luby et. al.(2004) show that diarrhea incidence can be sharply reduced in a region with poor water 
supply through hand washing. 27
households had to raise funds to finance healthcare, or, it could perversely raise wealth if 
families were able to save more due to fewer children.  
While these are each plausible, we doubt they play a significant role here.  We 
have examined child deaths which occurred in the previous five years to the study. Over 
half of these deaths occur in the first year of life.  As discussed in Section 2, and further 
discussed in Section 7, the vast majority of diseases would be easy and cheap to treat, 
hence prohibitively expensive treatment is unlikely to be the main reason children died.
26  
With the maximum timeframe of five years, we doubt child deaths contribute much to
higher savings.  
6.3  Reality check: Is such a large decline in mortality due to treatment and 
education plausible?
As a final robustness test, let’s consider whether it is reasonable to believe that 
parental education and raising the “propensity to treat” could truly generate the empirical 
declines in mortality risk that we estimate here.  According to our regression equations, 
holding fixed wealth, a one standard deviation rise in mother’s and father’s education 
(roughly 4 years each), along with a one standard deviation improvement in treatment, 
can generate a 40% decline in post-neonatal child mortality.
Table 2 outlines the WHO approved protocol for treatment of the main diseases 
that cause child deaths.  The first-line treatments listed here are inexpensive and easy to 
administer.
27  There are no trials that permit us to measure exactly what happens when a 
child receives a “poor” treatment regime compared to one that receives a “better” 
treatment regime.  However, we only need a modest absolute change in survival 
probabilities in order to make dramatic changes in mortality rates.  For example, if 
children are sick with disease ten times per year, and they face a case fatality rate of 
                                                
26 Acemoglu, D. and S. Johnson (2005) estimate, using the discovery of vaccines and antibiotics as 
instruments, that the impact of increased life expectancy on income per capita is near to zero.  Weil. D. 
(2005) estimates a larger impact of health on incomes, but his focus is on diseases that leave people sick 
during their working years, rather than factors that impact the first months of life.
27 The cost of oral antibiotics is roughly £0.25 per course. The cost of anti-malarials ranges from £0.25 to 
£1.50 depending on the type.28
0.025%, then the child mortality rate will be 117.  If you can reduce this case fatality rate 
to 0.005%, then the child mortality rate falls to 25.  We need to reduce the risk of death 
from each episode by just 0.02%.
Some studies have pointed out the potential empirical importance of treatment-
seeking and general health knowledge.  A recent WHO-sponsored study that reviewed 
the evidence in favor of twelve family- and community-based interventions that promote 
child survival, provides a summary of available evidence. This study concludes that
uncomplicated diarrhea, malaria and local infections can be cured at home with 
efficacious treatments.  They argue that ORT can prevent death from watery diarrhea in 
all but the most severe cases.  They state that improved home treatment of malaria has 
“the potential to have a large impact with one well-conducted study reporting a 41% 
mortality reduction”. Finally, they note that “poor care-seeking has been implicated in 6-
70% of [child] deaths” (Hill, Kirkwood et al. 2004).
A broader analysis of the potential to reduce mortality comes from the Bellagio 
Child Survival Study Group.  They calculated that the introduction of 24 basic health 
interventions, shown in Table 10, could generate a 63% decline in child mortality.  In 
Table 9 we show, where data is available, that our Treatment indicator is indeed 
correlated with parents’ adherence to several of these measures. 
7.  Implications for child health programs targeting reduced child mortality
In this section, we expand our discussion to calculate the impact of targeted
packages of measures aimed at reducing child mortality.  We then examine the key 
differences and issues that arise when we compare the solutions put forward by the 
Bellagio Child Survival Study Group with our findings.  We also discuss whether a large 
expansion of public health infrastructure is truly needed to reduce child deaths. 
7.1 What would be the impact of targeted programs to reduce morbidity, improve 
water and sanitation, raise education, or raise treatment levels?29
In order to predict the impact of major intervention programs, we need to consider 
not only the empirical impact of the intervention when we increase or add the services, 
but also the pattern of existing services to see how much room there is for further 
increases.  Figure 11 shows the impact of several alternative intervention programs on
Child Deaths based on our logit, matched data regression results.  
We calculate that expanding clean water and sanitation to 100% of the population 
would reduce child mortality by just 2%.  The low impact of these variables reflects the 
generally high coverage of water and sanitation in many regions, along with the low 
predicted impact of improved water, based on our regression results and discussed in 
section 5.2.
The second experiment measures the impact of halving the incidence of diarrhea, 
fever and ARI throughout all countries in our sample.  We’re not sure how this could be 
achieved, but even if it were achieved, we calculate that the impact would be to reduce 
mortality by just 3%.  This reflects the weak empirical relation between symptoms of 
common childhood diseases and mortality in our regression outcomes.
In our third experiment, we consider the impact of raising the propensity to treat 
children in all households to the 53
rd percentile of our global treatment indicator.  This is 
the level in Egypt today.  This may be achievable through targeted health education 
projects, such as a Nepalese study referred to below. We forecast child mortality would 
fall by 13% if this was achieved.
Finally, the fourth experiment illustrates the impact of greater education.  Here we 
examine the predicted outcomes if we raise the years of schooling for mothers and fathers 
to 6.3 and 8.3 respectively.  This is once more the level currently in Egypt.  We calculate 
that child mortality would fall by 19% if this were achieved.
7.2 Do we need to build out the public health sector in order to reduce mortality?
The empirical results in section 7.1 suggest that an aggressive program aimed at 
improving education (with health knowledge) and treatment-seeking could achieve very 
large declines in child mortality.30
Table 10 presents the 24 interventions recommended by the Bellagio Child 
Survival Group which they estimate would reduce child mortality by 63%.  At first 
glance, the main interventions promoted by the Bellagio Child Survival Study Group
appear completely unrelated to the results from our regressions.  However, we believe the 
relation is closer than it may appear.  The measures in Table 10 are not rocket science: 
they are generally simple and can be achieved by parents at modest cost to themselves, 
through treatment at home and access to very basic child health services.  Our regression 
results probably reflect that well educated households with high treatment indicators do 
implement a similar package of measures as listed in Table 10 to keep their children 
alive.
This is an extremely important issue with ramifications for how policy should be 
designed to reduce mortality.  Education could be essential for success for two key 
reasons: First, to the extent that political institutions respond to the demands of vocal and 
powerful citizens, these institutions probably do not strongly reflect the interests of 
marginal groups.  Education may be essential to ensure that marginalized groups have 
enough voice to receive public services (including better education itself).
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Second, it is probably easier for an educated person, and surely for a literate 
person, to learn about improved health practices, to perceive the value of such services,
and to seek out adequate healthcare. Since the parent is invariably the most important 
advocate for a child, and is the first one to observe or be able to prevent risk factors, it is 
natural that they, rather than the public health sector, play the essential role in 
determining child survival outcomes.  
This then raises the question: if we embark on a program to change education, 
health knowledge and treatment-seeking, so that parents follow or seek out the measures 
outlined in Table10, do we really need to build out the supply of public infrastructure, or 
can we rely on market forces to ensure that private supply expands to meet demand?
The Commission on Macroeconomics and Health argued that a large public build 
out was needed because the private sector could not be relied on to provide equitable, 
affordable services sufficient to reduce mortality.  However, they did not present 
                                                
28 Education will probably also change the distribution of services within the household, especially for 
girls.31
empirical evidence to justify this argument.
29 There is substantial variation in the size of 
the private sector in the 45 countries we examine, so it is possible for us to use this data 
to compare basic performance measures of public and private systems.    
We start by examining whether public systems provide a more equal distribution 
of healthcare across groups.  We do this using our treatment indicator and mortality 
outcomes.  Figures 12 and 13 plot the average level of treatment, and a GINI coefficient 
we calculated for treatment, against the size of the private health sector in the country.  
The chart shows clearly that neither public nor private systems perform better in terms of 
levels, or equity of the allocation of treatment.  Figure 14 shows the same conclusion can 
be drawn when examining mortality outcomes.  
One criticism that could be directed at our argument is that Figure 14 represents 
the average outcomes for the whole population, but it does not show us where the poor 
are receiving their healthcare.  It could be that low mortality is achieved only in countries 
where the public sector provides services to the very poor.  Figure 15 addresses the 
question directly and shows that even when we limit the analysis to the bottom wealth 
quartile of the population, we find a similar pattern.  The very poor can have low 
mortality rates in both public and private regimes, and there is no correlation between the 
ownership status of the health sector and mortality outcomes. 
In order to properly control for confounding factors, we also ran regressions 
where we included the relative size of the private sector in our treatment and mortality 
regressions.  We also interacted the size of the private sector with treatment to learn 
whether there was a different predicted impact of treatment according to the public or 
private nature of the health system.  These results are reported in Table 7 column III-V.  
They show that the size of the private sector is not significant in mortality or treatment 
regressions, implying again that the public and private sectors perform equally well.
Figure 14-15 allow us to draw one final conclusion.  It is interesting to note that 
there are many successful countries with both small and large private systems.  Vietnam 
has a large private sector despite being viewed as an example of a socialist success, and 
                                                
29 The Bellagio Child Survival Study Group was less decisive, although their general assumption was that the public 
sector would be responsible for most services, while the private sector “should be involved whenever possible, 
especially in monitoring and ensuring quality and equity” (Bryce, J., S. el Arifeen, et al. 2003).32
private spending accounts for 71% of total health spending (Adams 2005).
30  The same is 
true of Kerala, a state in India where healthcare success has often been attributed to many 
years of “communist” governments, where the poor reportedly seek out 60-70% of health 
care services in the private sector (Varatharajan, Thankappan et al. 2004).  Indonesia and 
Egypt are other countries with unusually low child mortality and a large private sector.  
Kazakhstan, Armenia and Peru are examples of countries with virtually exclusive public 
sectors and low mortality.  
7.3 Designing interventions to reduce child mortality
What does this imply for the design of intervention programs aimed at reducing 
child mortality?
Our first conclusion is that parental and child education, including efforts to 
rapidly improve health knowledge, should be a key component of any project, and, given 
the strong evidence that education matters, it would be a major gamble to assume that we 
can make large inroads without education.  Figure 11 suggests a package of education, 
health knowledge and treatment seeking measures could reduce child mortality by 32%.  
There is a surprising paucity of well-designed research trials examining how 
health-related education could impact survival outcomes, and the best means to achieve 
this.  A recent, large community-based intervention to reduce neonatal mortality in Nepal 
is an exception.  This project examined whether the formation of women’s groups to 
improve health knowledge and practices ahead of child birth would affect neonatal 
mortality.  They found neonatal mortality fell by 28% in the intervention areas compared 
to controls (Morrison, Tamang et al. 2005).
31
                                                
30 Adams, S. J. (2005) reports that the private sector pays 63% of healthcare spending in China.  The high 
private percentage in part reflects user costs in the public health system.
31 One additional example is a long-running project in rural Maharashtra called the Comprehensive Rural 
Health Project.  In this project, a self-financing private clinic was created to service a village population of 
150,000 people since the early 1970s.  The clinic was established to build credibility with the population; 
however the major intervention was the selection and training of village health workers to educate 
households on the causes of disease and child deaths, and to improve treatment-seeking and general health-
related behavior.  While there were no prospective controls in the region to compare outcomes with, the 
health outcomes do appear very promising when compared to rural regions in Maharashtra and the country 
as a whole.  Child mortality rates fell 68% during the first five years of the project, and today, despite 
general poverty, child mortality rates are near to levels in wealthy countries (Arole and Arole 1994).33
Our second conclusion is that we don’t necessarily need to build out a large public 
health system in order to achieve major declines in child mortality.  In fact, it seems les 
risky, and probably more sustainable in most poor countries, to concentrate on improving 
education and health knowledge which can be passed on within communities and across 
generations.  This empowers parents to seek out the best care for their children, and 
means they don’t need to rely on political elites, public sector capacity, and national 
financial stability, in order to gain better mortality outcomes.  
However, there are still important issues with ensuring proper supply.  
Communities may resist health education efforts when health services are not made 
available (Arole and Arole 1994).  Loevinsohn and Harding (2005) discuss promising 
experiments with contracting out health services to the private sector. It is also important 
to understand how best to target measures to ensure the extremely poor receive services.  
Gwatkin, Bhuiya et al. (2004) discusses several experiments with different delivery 
systems that aim to target services to the poor. Finally, there is a need to better 




Despite years of effort to reduce child mortality, with sound scientific knowledge 
of the causes of disease, simple and inexpensive treatments that prevent deaths, and 
substantial foreign assistance and goodwill, there are several million preventable child 
deaths each year. Our main goal for this paper was to examine why child mortality varies 
so much across poor countries, and what can be done to reduce mortality.  
The evidence we have presented suggests there is a route to low mortality that 
may achieve more, in regions where mortality remains high, than “traditional” programs 
which call for aggressive expansion of the public health sector.  In order for these 
traditional programs to succeed, we need to ensure that sick children are brought to 
                                                                                                                                                 
32 Our experience in trials to reduce child mortality in several remote regions of India and Africa is that the 
private sector covers most of the primary, secondary and tertiary services needed for maternal and child 
healthcare.  However, some services, such as blood banks, would need to be coordinated, and there is a role 
for greater regulation and pricing transparency.34
clinics in time, we need to structure the public system to ensure it provides adequate care, 
we need to raise large amounts of new financing, and we must sustain such healthcare 
despite volatile public finances, bouts of political instability, and a local elite that is often 
not interested in helping those communities that suffer from high mortality.    
Our evidence suggests an alternative route to low mortality. The biological bond 
between a parent and child ensures parents are every child’s greatest advocate. If we can 
help the parent, by providing better health knowledge and general education, we can
direct that powerful advocacy to tackle the causes of child deaths. If markets respond to 
parents who seek out appropriate care, a private healthcare sector could arise to provide 
adequate services.  This alternative route to low mortality characterizes the impetus for 
notable improvement in health system in many low income nations today, and it could 
prove a highly effective and sustainable path for other countries where child mortality is 
still too high.35
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Appendix 1:
Data glossary and descriptions not included in section 4
Child Deaths, Child Deaths 7+:
See Section 4 for description.  Child deaths is a dummy equal to one if the child died by 
the time of the interview, zero otherwise.  Child deaths 7+ is a dummy set to one if the 
child survived to seven days of age, but died subsequently, and zero if it survived past 
seven days of age.
Treatment:
See Section 4 for description.  The first principal component of a set of variables listed in 
Table 1.
Morbidity indicators:
See section 4 for description.  Each morbidity indicator is the cluster average for the 
household level data for the following symptoms/diseases:
 Diarrhea: A dummy set to one if a child had diarrhea in the household in the 
previous two weeks
 Cough with fast breathing: A dummy set to one if a child had cough with fast 
breathing in the household in the previous two weeks
 Fever:  A dummy set to one if a child had fever in the household in the previous 
two weeks
Wealth:
DHS provides a single wealth indicator for many countries based on a principal 
components analysis of multiple indicators of wealth.  We use this variable, however we 
exclude sanitation and water indicators when/if these are included in the DHS indicators.  
When DHS does not calculate a wealth variable, we have calculated a wealth index based 
on their methodology including, as best possible, the same variables they generally 
include when calculating their wealth index.
Education:
We used the years of schooling for the mother and father separately as measures for 
education. 
Improved Water:
We used the standard WHO definition of improved water. Our dummy variable assigns 
each individual a 1 if they use piped or covered well water, and otherwise a zero. The 
households with zero will typically have access to surface water, uncovered wells, or 
other sources that are more likely to be polluted.
Improved Sanitation:
We used the standard WHO definition of improved sanitation.  Our dummy variable is 
set to one if the individual use latrines, and zero otherwise. 39
Time to get to the water source:
Respondents are asked how many minutes it takes to get to their drinking source. We use 
this variable as an instrument for improved water in our robustness section.
Distance to nearest public health facility:
Where available this measures how far it is from the household to the nearest public 
health center.  Where this is not available, the variable captures whether mothers report:  
“when they are sick they do not seek healthcare for themselves because health services 
are ‘very far away’”.  The latter question is less satisfactory since health centers may be 
“very far” because a mother believes they are not very helpful. To the extent this is the 
case the coefficient may overestimate the impact of the variabl.
Months at Risk: 
Our regression equation calls for the months at risk to be included as an explanatory 
variable.  We calculate the total number of months that the child would be exposed to 
disease risk if the child lived to the date of the survey period.  This ensures that we 
calculate the total ex-ante “risk” facing the child, consistent with equation (2).
Health Knowledge:
In almost all DHS surveys they ask mothers whether they have heard of oral rehydration 
therapy (ORT), and whether they know of any modern methods of family-planning.  We 
created a variable using principal components from these two indicators.   
Other Controls:
We include national and regional dummy variables.  The DHS data generally does not 
provide village indicators but does provide state/provinces or larger general regional 
indicators.  We also include a dummy set to one if the household lives in an urban area. 
Additional control variables are described in our robustness discussion in Section 6.40
Table 1
Proportion of mothers and children that received the individual services used to 
generate Treatment
Ranking of household according to global 
Treatment indicator
Bottom 10% Middle 10% Top 10%
Percentage of mothers that had 
at least one antenatal visit 
during their last pregnancy 17% 78% 100%
Percentage of mothers whose last 
child was delivered at a hospital or 
health clinic 3% 82% 95%
Did your most recent living child 
receive these vaccinations?
BCG 0% 97% 100%
DPT1 7% 96% 100%
Poio1 28% 97% 100%
DPT2 3% 92% 100%
Polio2 16% 92% 100%
DPT3 0% 83% 100%
Polio3 0% 57% 100%
Source:  Authors calculations41
Table 2







Cough  Fast breathing, and/or,
chest indrawing, and/or
stridor in calm child





Fever No signs of pneumonia, 
measles, or severe febrile 
disease
Malaria Oral anti-malarial 
Lethargic or unconscious, 
sunken eyes, not able to drink, 
skin pinch goes back slowly, 
irritable
Severe or some 
dehydration
Fluid (ORT) and 
food.  Refer to 
hospital if severe.
Diarrhea
Blood in stool Dysentery Treat with oral 
antibiotic
Source:(World Health Organization 2006)
     42
Table 3

















Pre5>0 Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD
All countries 244278 0.058 0.200 0.036 0.158 0.000 1.568 0.22 0.17 0.20 0.17 0.37 0.21 0.64 0.48 0.60 0.49 4.5 4.6 5.7 4.9
Africa 121991 0.075 0.224 0.050 0.183 -0.114 1.640 0.24 0.17 0.19 0.16 0.41 0.20 0.61 0.49 0.60 0.49 3.3 4.1 4.4 4.8
Asia 78691 0.046 0.180 0.024 0.132 -0.048 1.580 0.18 0.17 0.18 0.17 0.31 0.20 0.67 0.47 0.54 0.50 5.3 4.9 7.0 4.8
Latin America 43596 0.034 0.155 0.020 0.117 0.371 1.273 0.21 0.18 0.26 0.21 0.35 0.21 0.66 0.47 0.73 0.44 6.1 4.5 6.8 4.6
Bangladesh 5421 0.049 0.188 0.025 0.132 0.187 1.194 0.09 0.08 0.22 0.13 0.45 0.16 0.96 0.19 0.89 0.31 3.9 3.8 4.3 4.5
Brazil 3808 0.032 0.146 0.020 0.116 0.960 1.062 0.17 0.18 0.27 0.22 0.32 0.22 0.92 0.26 0.82 0.38 5.8 3.8 5.4 4.0
Colombia 3656 0.019 0.124 0.008 0.078 0.773 1.079 0.17 0.19 NA NA 0.30 0.24 0.89 0.31 0.89 0.31 7.3 3.9 7.2 4.1
Egypt 4761 0.035 0.158 0.020 0.118 0.714 0.934 0.27 0.21 0.14 0.16 0.40 0.24 0.82 0.38 0.92 0.27 6.3 5.8 8.3 5.6
Ethiopia 7276 0.083 0.237 0.054 0.193 -1.517 1.632 0.30 0.16 0.28 0.16 0.37 0.18 0.62 0.49 0.20 0.40 1.2 2.8 2.3 3.9
Ghana 2789 0.058 0.205 0.027 0.139 0.394 1.298 0.21 0.17 0.13 0.15 0.27 0.19 0.39 0.49 0.60 0.49 4.1 4.5 6.0 5.7
India 39601 0.056 0.196 0.030 0.143 -0.455 1.751 0.21 0.17 0.21 0.17 0.32 0.19 0.77 0.42 0.40 0.49 3.9 4.7 6.4 5.0
Indonesia 15542 0.032 0.159 0.018 0.120 0.132 1.460 0.11 0.13 0.09 0.13 0.28 0.21 0.39 0.49 0.57 0.49 7.9 3.9 8.4 4.1
Kenya 3996 0.060 0.205 0.036 0.156 0.241 1.376 0.21 0.17 0.23 0.16 0.49 0.21 0.38 0.49 0.75 0.43 6.6 4.2 7.6 4.6
Morocco 4813 0.032 0.152 0.016 0.107 0.825 0.980 0.14 0.13 0.14 0.14 0.30 0.19 0.73 0.44 0.75 0.43 2.6 4.3 4.0 5.0
Mozambique 7035 0.087 0.244 0.063 0.209 0.307 1.526 0.18 0.13 0.13 0.13 0.33 0.19 0.62 0.48 0.55 0.50 2.5 2.8 4.1 3.3
Nepal 4766 0.053 0.185 0.028 0.135 -0.040 1.275 0.25 0.13 0.28 0.18 0.38 0.15 0.38 0.48 0.25 0.43 1.5 3.0 4.5 4.2
Nigeria 3791 0.087 0.232 0.055 0.184 -1.228 1.650 0.24 0.19 0.14 0.14 0.40 0.20 0.49 0.50 0.71 0.45 4.2 4.8 5.8 5.6
Peru 10604 0.030 0.150 0.017 0.112 0.495 1.153 0.20 0.17 0.22 0.18 0.31 0.19 0.70 0.46 0.66 0.47 7.4 4.4 8.9 4.0
Phillippines 4962 0.026 0.138 0.013 0.098 0.512 1.283 0.14 0.16 0.13 0.15 0.30 0.21 0.55 0.50 0.83 0.37 9.0 3.9 8.7 4.1
South Africa 4187 0.043 0.191 0.031 0.162 0.631 1.147 0.16 0.18 0.21 0.21 NA NA 0.78 0.41 0.83 0.38 8.3 3.8 7.6 4.4
Tanzania 2137 0.089 0.244 0.060 0.200 0.760 1.034 0.17 0.12 0.20 0.13 0.45 0.19 0.79 0.40 0.80 0.40 5.1 3.7 NA NA
Turkey 2695 0.032 0.147 0.015 0.098 0.156 1.404 0.36 0.25 NA NA NA NA 0.69 0.46 0.97 0.17 5.0 3.7 7.0 3.9
Uganda 4275 0.072 0.210 0.049 0.173 0.056 1.363 0.27 0.16 0.28 0.16 0.53 0.23 0.38 0.48 0.83 0.38 4.4 3.8 6.6 4.2
Vietnam 1906 0.011 0.093 0.005 0.060 0.590 1.302 0.11 0.14 0.20 0.18 0.28 0.21 0.74 0.44 0.78 0.41 7.1 3.8 7.8 3.7
Source:  Calculated from DHS survey data for each country, see text for definitions43
Table 4
Examples of Regression results from the four largest countries by population
(Dependent variable:  Child Deaths 7+)
Bangladesh Brazil India Indonesia
I II I II I II I II
Treatment   -0.156
***   -0.157
***   -0.201
***   -0.198
***   -0.031 -0.030 -0.182
***   -0.190
***
(0.036) (0.036) (0.062) (0.062) (0.022) (0.022) (0.041) (0.042)
Diarrhea 0.620 0.301   0.363
** -0.134
(0.828) (0.645) (0.178) (0.663)
-0.455 -0.624 0.051   1.338
** Cough & 
Fast Breathing (0.582) (0.599) (0.190) (0.578)
Fever 1.035
* -0.315 0.141 -0.591
(0.537) (0.545) (0.176) (0.450)
-0.393 0.233 0.039 0.052
Improved Water (0.322) (0.378) (0.104) (0.149)
-0.094 -0.196 -0.029 -0.045










Mother’s education  (0.029) (0.029) (0.037) (0.038) (0.010) (0.010) (0.025) (0.025)
0.000   -0.001   -0.158
***   -0.158
***   -0.018




Father’s Education (0.023) (0.023) (0.051) (0.051) (0.007) (0.007) (0.025) (0.026)
Urban 0.190 0.194 0.270 0.293 0.038 0.050 -0.549
***   -0.539
***
(0.161) (0.162) (0.280) (0.289) (0.079) (0.082) (0.193) (0.186)
   0.015
***    0.015
***    0.020
***    0.020
***    0.037
***    0.037
***     0.014
***    0.014
***
Months at risk (0.004) (0.004) (0.006) (0.005) (0.001) (0.001) (0.005) (0.005)
Wealth -0.056 -0.058   -0.037 0.000 -0.108
***   -0.106
***   -0.032   -0.034
(0.041) (0.041) (0.065) (0.062) (0.017) (0.018) (0.031) (0.031)
Seasonal dummies Yes Yes Yes Yes
State/Region dummies Yes Yes Yes Yes Yes Yes Yes Yes
Diagnostic statistics:




0.182 0.434 0.510 0.699 0.048 0.877 0.113 0.900
N 6753 6746 3504 3495 41508 41504 17596 17537
Probability > F 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000
F 7.76 9.14 4.93 5.64 31.47 34.77 7.47 7.14
Note:  See section 5.1 for a description of the regressions.  Child Deaths 7+ is a dummy variable set to zero if the 
child is alive, and one if the died more than seven days after birth.
***:  denotes coefficient significant at 1% level
**:   denotes coefficient significant at 5% level
*:    denotes coefficient significant at 10% level44
Table 5:
Results from global regressions












Treatment    -0.1164
***    -0.1123
***    -0.0079
***   -0.0057
***   -0.0043
***
(0.0073) (0.0065) (0.0011) (0.0003) (0.0009)
Diarrhea    0.3475
***     0.3083
***     0.0150
***     0.0151
***     0.0154
***
(0.0691) (0.0611) (0.0042) (0.0027) (0.0034)
0.0136 -0.0344    -0.0048    -0.0003 0.0000 Cough & 
Fast Breathing (0.0748) (0.0659) (0.0037) (0.0029) (0.0033)
Fever   0.1569
**     0.1444
***    0.0101
**    0.0062
*** 0.0063
*
(0.0624) (0.0548) (0.0040) (0.0024) (0.0034)
-0.0257
***   -0.0306
***   -0.0015
*** -0.0003
**    -0.0003 Mother’s 
Education (0.0044) (0.0038) (0.0004) (0.0001) (0.0002)
-0.0210
***   -0.0203
***    -0.0009   -0.0007
***   -0.0007
*** Father’s
Education (0.0034) (0.0029) (0.0004) (0.0001) (0.0001)
Urban -0.0641
** -0.0265 0.0014 -0.0021
**    -0.0026
*
(0.0315) (0.0270) (0.0015) (0.0010) (0.0015)
Months at risk   0.0325
***      0.0242
***    0.0005
***    0.0013
***    0.0013
***




Yes Yes Yes Yes Yes
Seasonal 
Dummies
Yes Yes Yes Yes Yes
Country 
Dummies





N   271639 278601 27092 271641 271641
Prob > F 0.0000 0.0000 0.0000 0.0000 0.0000
Note:  See section 5.2 for a description of regressions. Child Deaths 7+ is a dummy variable set to zero if the child 
is alive, and one if the died more than seven days after birth.
***:  denotes coefficient significant at 1% level
**:   denotes coefficient significant at 5% level
*:    denotes coefficient significant at 10% level45
Table 6
Results from global regressions












Treatment    -0.1195
***   -0.1150
***   -0.0084
***   -0.0057
***   -0.0045
***
(0.0073) (0.0065) (0.0010) (0.0003) (0.0009)
   -0.0023   -0.0171 0.0006 0.0000    -0.0001
Improved water (0.0221) (0.0193) (0.0019) (0.0009) (0.0009)
   -0.0124    -0.0224    -0.0018    -0.0010    -0.0013
Improved sanitation (0.0265) (0.0234) (0.0035) (0.0010) (0.0014)
  -0.0273
***   -0.0318
***   -0.0017
***   -0.0004
*** -0.0003
** Mother’s 
Education (0.0044) (0.0038) (0.0004) (0.0001) (0.0002)
  -0.0193
***   -0.0189
*** -0.0008
*   -0.0007
***   -0.0006
*** Father’s 
Education (0.0034) (0.0029) (0.0004) (0.0001) (0.0001)
Urban -0.0584
*    -0.0152 0.0019 -0.0019
*    -0.0023
(0.0315) (0.0270) (0.0016) (0.0011) (0.0015)
Months at risk     0.0325
***     0.0242
***     0.0004
***     0.0013
***     0.0013
***
(0.0006) (0.0005) (0.0001) (0.0000) (0.0002)
Wealth variable 
for each country
Yes Yes Yes Yes Yes
Country 
Dummies





N   270929 277862 27092 270929 270929
Prob > F 0.0000 0.0000 0.0000 0.0000 0.0000
Note:  See section 5.2 for a description of the regressions.  Child Deaths 7+ is a dummy variable set to zero if the 
child is alive, and one if the died more than seven days after birth.
***:  denotes coefficient significant at 1% level
**:   denotes coefficient significant at 5% level
*:    denotes coefficient significant at 10% level46
Table 7
The determinants of treatment, and the relation between child mortality, treatment and the share of 
child health services sought in the private sector
Dependent variable:
Treatment




matched data, child 
outcomes)
I II III IV V
Treatment   -0.112
***   -0.107
***
0.006 0.008
     -0.022 Treatment* (Share of child 
health services sought in the 
private sector)
0.020
0.069 0.019 Share of child health services 
sought in the private sector 0.064 0.044
Mother’s years of schooling     0.062
***     0.068
***     0.068
***   -0.031
***   -0.031
***
0.008 0.010 0.010 0.004 0.004
Father’s years of schooling     0.030
***     0.029
***    0.029
***   -0.020
***   -0.020
***
0.005 0.006 0.006 0.003 0.003
Urban     0.284
***     0.209
***   0.208
*** -0.026 -0.026
0.052 0.038 0.040 0.027 0.027
  -0.214
***   -0.208
*** Distance to nearest public health 
center 0.069 0.068
Diarrhea     0.308
***     0.300
***
0.061 0.061
-0.034 -0.030 Cough & 
Fast Breathing 0.066 0.066
Fever    0.144
**   0.124
**
0.055 0.055
-0.014 -0.020 -0.020 Number of children in household 
at start of observation period 0.011 0.016  0.016
Months at risk     0.024
***     0.024
***
0.000 0.000
Yes Yes Yes Yes Yes Wealth indicators for each 
country Yes Yes Yes Yes Yes
Seasonal dummies by country Yes Yes
Country dummies Yes Yes Yes Yes Yes
Number of observations  191453 127036 123721 278601 273937
Prob > F 0.0000 0.0000 0.0000 0.0000 0.0000
Note:  See section 5.4 and 7.2 for a description of the regressions. Child Deaths 7+ is a dummy variable set to zero 
if the child is alive, and one if the died more than seven days after birth.
***:  denotes coefficient significant at 1% level, 
**denotes coefficient significant at 5% level,
* denotes coefficient 
significant at the 10% level.47
Table 8
Robustness tests for the impact of improved water in Indian Village Data 
and Global Data
Dataset Indian Villages Global matched
Dependent 
variable:
Child Deaths 7+ Child Deaths 7+
Instrument Access to surface water 
for agriculture
Time needed to get 
drinking water
OLS IV OLS IV
Treatment -0.0056 -0.0051 -0.0057
*** -0.0057
***
(0.0037) (0.0040) (0.0007) (0.0007)
Improved Water 0.0241 0.0727 0.0000 -0.0049
(0.0172) (0.1623) (0.0009) (0.0071)
0.0171 0.0170 -0.0010 -0.0005 Improved 
sanitation (0.0161) (0.0163) (0.0014) (0.0011)
-0.0034 -0.0033 -0.0004
*** -0.0004
*** Mother’s years of 
schooling (0.0023) (0.0023) (0.0001) (0.0001)
-0.0010 -0.0008 -0.0007
*** -0.0007
*** Father’s years of 
schooling (0.0015) (0.0016) (0.0001) (0.0001)
0.0008 0.0007 0.0013
*** 0.0013
*** Months at Risk
(0.0006) (0.0007) (0.0002) (0.0002)
-0.0036 -0.0042 Yes Yes Wealth
(0.0027) (0.0032) Yes Yes
Seasonal dummies No No No No
Country dummies Yes Yes Yes Yes
Number of 
observations   508 508 270929 270929
F 2.5900 2.4900 .
R-squared 0.14 0.13 0.03 0.03
                      Note:  See section 6.2.1 for a description of the regressions. Child Deaths 7+ is a dummy variable set
 to zero if the child is alive, and one if the died more than seven days after birth.
            ***:  denotes coefficient significant at 1% level
              **:   denotes coefficient significant at 5% level
                *:    denotes coefficient significant at 10% level48
Table 9
Proportion of mothers and children that received specific maternal and child 
healthcare services 
(these services were not used to compute the treatment index)
Ranking of household according to global 
Treatment indicator
Bottom 10% Middle 10% Top 10%
For a child with the following 
symptoms of illness during the last 
two weeks, did you seek out any 
treatment?
Diarrhea 32 49 53
Cough or fever 36 65 67
The percentage of mothers that 
followed WHO recommended 
practices related to breast feeding:
Breastfed child within one hour after 
birth 40 60 59
Breastfed child for first six months 98 99 88
Percentage of households where the 
youngest son aged 10 months or 
over has been vaccinated for 
measles 6 89 9249
Table 10
The 24 Intervention Measures proposed by the Bellagio Child Survival Study Group
Exclusive breastfeeding (0-6 
months)
Counseling to give only breastmilk to children from birth to 6 months of age
Breastfeeding (6-11 months) Counseling to continue breastfeeding, on demand if possible, from 6 to 11 
months of age 
Complementary feeding Counseling on proper feeding of infants 6-23 months of age with adequate and 
safe foods in addition to breastmilk, and growth monitoring and promotion.
Zinc Four rounds of zinc supplements given to caretaker when child is between 2 
and 23 months of age
Vitamin A One dose delivered six months from 7 to 59 months; 9 doses total 
Measles vaccine One dose at 9 months.
Hib vaccine Three doses within 1
st year, delivered with DPT
Tetanus toxoid Two doses during pregnancy
Clean delivery (skilled attendant at 
birth)
“Essential newborn care”: clean hands, clean perineum, nothing unclean 
introduced into vagina, clean delivery surface, cleanliness in cutting the 
umbilical cord, cleanliness for cord care of newborn
Newborn temperature management Thermal protection for all newborns and provision of extra care for low 
birthweight babies, including "kangaroo mother care" which entails nursing 
the stable, low birthweight baby  skin-to-skin and tied to the mother's front
Antibiotics for preterm premature 
rupture of membranes (PPROM)
Oral erythromycin 250 mg 8 hourly x 7 days for PPROM before delivery
Antenatal Steroids Two injections of betamethasone after onset of premature labour 
Nevirapine and replacement feeding Anti-retroviral drugs for the mother (Nevirapine) and breastmilk substitute 
(formula) for 12 months.
Insecticide-treated materials One impregnated net every three years for each HH with ≥ 1 child under five   
Antimalarial intermittent preventive 
treatment in pregnancy
Minimum 3 doses of sulfadoxine-pyrimethamine  (SP, or Fansidar) within the 
2
nd & 3
rd trimesters  of each pregnancy.  Dose = 3 tablets of 500 S +25 mg P  
Water, sanitation, hygiene Provision of equipment and materials needed to move from UNICEF category 
of access to safe water “not improved” to least costly country-specific 
“improved” access to safe water 
Zinc for diarrhea Zinc suspension or dispersable tablet for 10 days (20mg)
Vitamin A for tx of measles Vitamin A  (200,000 units) 
Oral rehydration therapy For children with at least some dehydration, ORS in facility (1 sachet 
administered and 2 sent home with mother); at home, ORT/increased fluids 
and continued feeding
Antibiotics for dysentery Ciprofloxacin (150mg/day for 3 days) + zinc suspension or dispersable table 
for 10 days + ORT (3 sachets)
Antibiotics for pneumonia Amoxicillin (500mg/day for 3 days)
Antibiotics for sepsis Tx course of injectable gentimicin and injectable ampicillin for 7 days 
Newborn resuscitation Resuscitation of newborn who is not breathing using bag and mask
Antimalarials Effective antimalarial 50
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Source:  calculated from Demographic Health Surveys in 45 countries52
Figure 3:  Estimated causes of neonatal and post-neonatal child deaths(2003)











Source: Black et. al. (2003)53











          
Source: Black et. al. (2003)54
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Figure 5a:  The impact of a one standard deviation rise in treatment on the












































Note:  Dotted lines show +/- 2 standard deviation bands around point estimates.
Figure 5b:  The impact of a one standard deviation fall in the prevalence of 













































Note:  Dotted lines show +/- 2 standard deviation bands around point estimates.56
Figure 5c:  The impact of a one standard deviation fall in the prevalence of 













































Note:  Dotted lines show +/- 2 standard deviation bands around point estimates.
Figure 5d:  The impact of a one standard deviation fall in the prevalence of 













































Note:  Dotted lines show +/- 2 standard deviation bands around point estimates.57
Figure 5e:  The impact of a one standard deviation rise in years of mothers’ 















































Note:  Dotted lines show +/- 2 standard deviation bands around point estimates.
Figure 5f:  The impact of a one standard deviation rise in years of father’s













































Note:  Dotted lines show +/- 2 standard deviation bands around point estimates58
Figure 5g:  The impact of a one standard deviation rise in wealth on the 













































Note:  Dotted lines show +/- 2 standard deviation bands around point estimates59
Figure 6a:  The impact of a one standard deviation rise in improved water on 












































Note:  Dotted lines show +/- 2 standard deviation bands around point estimates
Figure 6b:  The impact of a one standard deviation rise in improved sanitation 












































Note:  Dotted lines show +/- 2 standard deviation bands around point estim60
Figure 7:  The average impact of a one standard deviation change in 








Logit using matched data
OLS using clusters with matched data
OLS unadjusted data







Note: The chart shows the predicted impact of a one standard deviation rise in Treatment, a one standard deviation 
rise in mother’s year’s of schooling, and a one standard deviation rise in father’s years of schooling .  “Morbidity”
shows the combined impact of a one standard deviation fall in diarrhea, cough with fast breathing and fever.
Source:  Calculations based on regression results from Table 5.61
Figure 8:  The average impact of a one standard deviation change in 








Logit using matched data
OLS using clusters with matched data
OLS unadjusted data








Note: The chart shows the predicted impact of a one standard deviation rise of Treatment, the combined impact of a 
one standard deviation increase in improved water and sanitation, and the impact of a one standard deviation rise in 
years of mother’s and father’s education respectively.  
Source:  Calculations based on regression results from Table 6.62
Figure 9:  The impact of a one standard deviation rise in “Health Knowledge on 





































Figure 10:  The average impact of a one standard deviation change in 

















Logit - base case Health knowledge added
Malaria endemic regions  Size of private sector







1.  The chart shows the predicted impact of a one standard deviation rise of treatment, the combined impact of a one 
standard deviation increase in improved water and sanitation, and the impact of a one standard deviation rise in 
years of mother’s and father’s education respectively.  “Morbidity” shows the combined impact of a one standard 
deviation fall in diarrhea, cough with fast breathing and fever
2.  These results are calculated from the following regressions:
Logit-base case:  Global matched data as in Table 5, column 2
Health knowledge added:  Health knowledge variable added as control to base case
Malaria endemic regions:  Interaction term for malaria endemic zones with fever added as control to base case
Size of private sector:  Proportion of child health services in the private sector for each cluster interacted with 
treatment and added as a regressor to base case
Mother’s age and low birth weight:  Mother’s age and a dummy variable equal to one if child was “small or very 
small” at birth added to regression equation 
Child Deaths as dependent variable:  Child Deaths instead of Child Deaths 7+, i.e. including children that died 
during the first seven days after birth, as the dependent variable in base case.64
Figure 11:  The impact of four alternative packages aimed at reducing child 






















propensity in all 
households 
to the average level 
in Egypt
-19%





The chart shows the point estimates for the impact of changes to right hand side variables based on the regression 
results using logit matched-data as reported in Table 5, and the similar regression in Table 6 when we calculate the 
impact of improved water and sanitation.
  65
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Figure 13:  Inequality of treatment and the share of child health services 
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Figure 14:  Child Deaths 7+ compared to the share of child health services 
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Figure 15:  Child Deaths 7+ compared to the share of child health services 
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